Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Doxil, Paclitaxel, Cyclophosphamide, and Avastin for Locally Advanced Breast Cancer
NCT00635050Phase 2Completed
- Sponsor
- University of Alabama at Birmingham
- Start
- Mar 2008
- Primary completion
- Dec 2014
- Countries
- 1
01
Overview
A Phase 2 trial of bevacizumab in invasive breast cancer, sponsored by University of Alabama at Birmingham. Started Mar 2008; status: completed.
02
Drugs
bevacizumab
03
Conditions
invasive breast cancer
Beyond the preview
Go deeper on NCT00635050.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00635050.